As of January 22, 2025, Aldeyra Therapeutics (ALDX) has a market cap of $0.30 billion USD. According to our data, Aldeyra Therapeutics is ranked No.6696 in global market value.
Year | Market Cap | %Change |
---|---|---|
Jan 22, 2025 | $0.30 B |
0.80%
|
Dec 31, 2024 | $0.30 B |
42.17%
|
Dec 29, 2023 | $0.21 B |
-49.57%
|
Dec 30, 2022 | $0.41 B |
74.00%
|
Dec 31, 2021 | $0.24 B |
-41.69%
|
Dec 31, 2020 | $0.41 B |
18.07%
|
Dec 31, 2019 | $0.35 B |
-30.00%
|
Dec 31, 2018 | $0.49 B |
22.06%
|
Dec 29, 2017 | $0.40 B |
27.10%
|
Dec 30, 2016 | $0.32 B |
-21.09%
|
Dec 31, 2015 | $0.40 B |
-6.09%
|
Dec 31, 2014 | $0.43 B |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
Apellis Pharmaceuticals
APLS
|
$3.78 B |
-0.000 M
|
USA
|
Kala Pharmaceuticals
KALA
|
$36.53 M |
0.000 M
|
USA
|
Ocular Therapeutix
OCUL
|
$1.26 B |
-0.000 M
|
USA
|
EyePoint Pharmaceuticals
EYPT
|
$0.60 B |
-0.000 M
|
USA
|
Regeneron Pharmaceuticals
REGN
|
$74.73 B |
1.236 B
|
USA
|
Novartis
NVS
|
$196.27 B |
-0.007 M
|
Switzerland
|
Alcon
ALC
|
$43.91 B |
-0.001 M
|
Switzerland
|
Bausch Health
BHC
|
$2.85 B |
6.423 M
|
Canada
|
Pfizer
PFE
|
$147.40 B |
-0.003 M
|
USA
|
Johnson & Johnson
JNJ
|
$349.75 B |
0.001 M
|
USA
|
Market Cap | = | ALDX Stock Price | * | ALDX Shares Outstanding |
= | $5.03 | * | 59.55 M | |
= | $0.30 B |